Teva Pharmaceutical Industries Limited
A maker of generic medicines, biosimilars, and brand-name drugs, Teva is one of the world's largest generic drugmakers. Its products treat conditions like multiple sclerosis (COPAXONE), migraine (AJOVY), and Huntington's chorea (AUSTEDO), used by patients and health systems worldwide. Founded in 1901 in Jerusalem as a small medicine wholesaler that shipped goods by mule and camel, it took the name "Teva"—the Hebrew word for "nature"—in the 1930s.
American Depositary Receipt (ADR) representing 1 ordinary share of Teva Pharmaceutical Industries Ltd
Granted 124.7K
Granted 1.54M
Granted 2.35M · Sold 1.18M
Granted 119.8K · Bought 750.0K · Sold 1.13M
Granted 232.5K · Bought 215.5K
Granted 371.6K · Bought 2.0K · Sold 210.1K
Granted 515.0K · Sold 386.3K
Granted 124.7K
Granted 124.7K · Sold 2.9K
Granted 119.8K
Granted 111.9K
Granted 440.6K · Sold 332.8K
Granted 6.7K
Granted 1.28M · Sold 1.24M
Granted 73.7K
Granted 73.2K
Granted 950.9K · Sold 885.3K
Granted 63.7K
Granted 185.7K · Sold 122.1K
Granted 58.8K
Granted 1.30M · Sold 1.25M
Granted 50.4K · Sold 5.3K
Granted 41.2K
Granted 85.8K · Sold 41.7K
Granted 55.8K · Sold 24.9K
Granted 22.5K
Granted 27.0K · Sold 20.2K
Granted 86.1K · Sold 97.2K
Granted 19.3K
Granted 9.7K · Sold 4.2K
Granted 8.9K · Sold 2.9K
Granted 156.1K · Sold 142.1K
Granted 16.7K · Bought 1.1K · Sold 4.8K
Granted 12.9K · Sold 4.1K
Granted 15.3K · Sold 5.1K
Granted 417.3K · Sold 417.3K
Granted 373.4K · Sold 379.1K
Granted 117.5K · Sold 121.0K
Granted 49.7K · Sold 49.7K
Granted 23.7K · Sold 23.3K
Granted 21.5K · Sold 21.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Elstein AmirDirector · 11 transactions | — | 2.12M | 124.7K | — | — |
| Schultz KarePresident and CEO, Director · 15 transactions | — | 1.54Mas of Nov 2022 | 1.54M | — | — |
| Francis Richard DPresident and CEO · 26 transactions | — | 1.18M | 2.35M | — | 1.18M |
| Mignone RobertoDirector · 16 transactions | — | 487.4K | 119.8K | 750.0K | 1.13M |
| Barer Sol JDirector · 14 transactions | — | 448.0K | 232.5K | 215.5K | — |
| Suesskind Dan SDirector · 1 transaction | — | 318.8Kas of Jan 2018 | — | — | — |
| Dethlefs SvenEVP, North America Commercial · 48 transactions | — | 165.4Kas of Mar 2023 | 371.6K | 2.0K | 210.1K |
| Drape EricExecutive VP Global Operations · 46 transactions | — | 145.9Kas of Mar 2024 | 515.0K | — | 386.3K |
| Lieberman Gerald MDirector · 11 transactions | — | 130.1K | 124.7K | — | — |
| Crane Rosemary ADirector · 12 transactions | — | 127.7K | 124.7K | — | 2.9K |
| Nisen PerryDirector · 9 transactions | — | 119.8K | 119.8K | — | — |
| Satchi-Fainaro RonitDirector · 9 transactions | — | 112.4K | 111.9K | — | — |
| Hughes Eric ASee "Remarks" · 23 transactions | — | 107.7K | 440.6K | — | 332.8K |
| Bergwerk DovActing Chief Legal Officer · 1 transaction | — | 97.0Kas of Feb 2024 | 6.7K | — | — |
| Sabag MarkSee "Remarks" · 48 transactions | — | 80.8K | 1.28M | — | 1.24M |
| Vergis Janet S.Director · 5 transactions | — | 73.7Kas of Jun 2025 | 73.7K | — | — |
| Zaks Tal ZviDirector · 6 transactions | — | 73.3K | 73.2K | — | — |
| Kalif Eliyahu SharonEVP, Chief Financial Officer · 33 transactions | — | 65.6K | 950.9K | — | 885.3K |
| Halfon Jean MichelDirector · 7 transactions | — | 63.7Kas of Jun 2022 | 63.7K | — | — |
| Fox ChristineEVP, U.S. Commercial · 13 transactions | — | 63.6K | 185.7K | — | 122.1K |
| Peres Nechemia JacobDirector · 5 transactions | — | 58.8Kas of Jun 2022 | 58.8K | — | — |
| Daniell RichardEVP, Europe Commercial · 99 transactions | — | 55.8K | 1.30M | — | 1.25M |
| Shani EliEVP,Global Marketing&Portfolio · 9 transactions | — | 54.2Kas of Mar 2023 | 50.4K | — | 5.3K |
| Inbar GaliaSee "Remarks" · 5 transactions | — | 46.0Kas of Mar 2023 | 41.2K | — | — |
| Lippman EvanEVP, Business Development · 4 transactions | — | 44.2K | 85.8K | — | 41.7K |
| de Notaristefani CarloExecutive VP Global Operations · 8 transactions | — | 33.6Kas of May 2019 | 55.8K | — | 24.9K |
| Shalev VardaDirector · 2 transactions | — | 22.5Kas of Jun 2025 | 22.5K | — | — |
| Jover PlacidSee "Remarks" · 4 transactions | — | 20.9K | 27.0K | — | 20.2K |
| Weiss AmirChief Accounting Officer · 24 transactions | — | 20.0K | 86.1K | — | 97.2K |
| Lichtenstein ChenDirector · 2 transactions | — | 19.3K | 19.3K | — | — |
| Codner Iris BeckEVP Global Brand&Communication · 3 transactions | — | 18.0Kas of Feb 2019 | 9.7K | — | 4.2K |
| McClellan Michael JamesEVP, Chief Financial Officer · 14 transactions | — | 16.1Kas of Nov 2019 | 8.9K | — | 2.9K |
| O'Grady Brendan P.EVP, North America Commercial · 37 transactions | — | 14.9Kas of Mar 2021 | 156.1K | — | 142.1K |
| McAvoy David R.EVP, Chief Legal Officer · 4 transactions | — | 13.0K | 16.7K | 1.1K | 4.8K |
| Grant AngusEVP, Business Development · 2 transactions | — | 12.9Kas of Aug 2024 | 12.9K | — | 4.1K |
| Savage BrianInterim Chief Legal Officer · 8 transactions | — | 10.9K | 15.3K | — | 5.1K |
| Stark David MatthewExec. VP Chief Legal Officer · 50 transactions | — | 3.0Kas of Mar 2023 | 417.3K | — | 417.3K |
| Fridriksdottir HafrunExecutive VP, Global R&D · 59 transactions | — | 1.4Kas of May 2022 | 373.4K | — | 379.1K |
| Nazzi GianfrancoEVP, International Markets · 33 transactions | — | 0as of Mar 2021 | 117.5K | — | 121.0K |
| Shields MatthewEVP, Global Operations · 7 transactions | — | 0 | 49.7K | — | 49.7K |
| Griffin Deborah AChief Accounting Officer · 27 transactions | — | 0as of Mar 2020 | 23.7K | — | 23.3K |
| Conway Vikki LSee "Remarks" · 9 transactions | — | 0as of May 2024 | 21.5K | — | 21.5K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -7.13M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.